Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Pathogenic bacterial colonization in intestine" refers not to a single molecule, receptor, or protein but rather the process by which disease-causing bacteria establish themselves within the intestinal tract. This is a complex ecological and pathological phenomenon involving interactions between invading pathogens (such as Salmonella enterica serovar Typhimurium, Clostridioides difficile, Campylobacter jejuni), the resident gut microbiota, host immune responses, and environmental factors such as diet and antibiotic use[1][2][3][4]. Pathogens employ various mechanisms—such as exploiting metabolites produced by commensal bacteria, utilizing inflammation-induced changes like increased nitrate availability for respiration, overcoming bile acids and antimicrobial peptides—to outcompete native microbes and persist within the gut environment[1][2]. The process is central to many gastrointestinal infections but does not represent a discrete molecular target; rather it encompasses multiple microbial species employing diverse virulence factors. Therefore this entry is not a canonical therapeutic target such as an enzyme or receptor but describes a pathophysiological state/process. Because "Pathogenic bacterial colonization in intestine" is not itself a molecule/receptor/target but instead describes an infectious process involving many organisms and mechanisms across different molecular classes—and lacks specificity—it should be flagged as incorrect if used where only discrete targets are appropriate.
Disruption of microbial community by antibiotics can allow pathogens to establish and expand[4]. Probiotics or commensals may compete with pathogens for nutrients or produce inhibitory metabolites[2]. Some drugs target specific virulence factors or metabolic pathways required for pathogen survival.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pathogenic bacterial colonization in intestine.